SCHEMBL7424979

SCHEMBL7424979

O=C(O)c1ccc2c3c(n(Cc4ccccc4Cl)c2c1)C(=O)CC3

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FABP4 P15090 1/20 0.51
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 1/20 0.46
HPGD P15428 1/20 0.46
TSHR P16473 1/20 0.46
HSD17B10 Q99714 1/20 0.46
CCR2 P41597 1/20 0.45
PTPN11 Q06124 1/20 0.44
DPP4 P27487 3/20 0.44
SLC22A12 Q96S37 2/20 0.43
MEN1 O00255 2/20 0.42
KMT2A Q03164 2/20 0.42
AKR1B10 O60218 2/20 0.42
AKR1A1 P14550 2/20 0.42
AKR1B1 P15121 2/20 0.42
EGLN3 Q9H6Z9 1/20 0.41
NPC1 O15118 1/20 0.40
CASP3 P42574 1/20 0.40
RAB9A P51151 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7416251 0.94 ALDH1A1 (0.54) FABP4ALDH1A1KDM4EHPGDTSHR
SCHEMBL7467571 0.90 DPP4 (0.44) FABP4ALDH1A1CCR2DPP4MEN1
SCHEMBL7470778 0.88 DPP4 (0.46) ALDH1A1KDM4EHPGDDPP4MEN1
SCHEMBL7418839 0.85 FABP4 (0.54) FABP4ALDH1A1CCR2PTPN11DPP4
SCHEMBL7423051 0.84 DPP4 (0.45) FABP4ALDH1A1KDM4EHPGDTSHR
SCHEMBL7473906 0.83 ALDH1A1 (0.43) FABP4ALDH1A1KDM4EHPGDTSHR
SCHEMBL7422984 0.82 DPP4 (0.47) FABP4ALDH1A1KDM4EHPGDTSHR
SCHEMBL7422336 0.81 FABP4 (0.57) FABP4ALDH1A1KDM4EHPGDTSHR
SCHEMBL7371603 0.78 ALDH1A1 (0.58) FABP4ALDH1A1KDM4EHPGDTSHR
SCHEMBL7374915 0.78 IP6K1 (0.39) FABP4ALDH1A1KDM4EHPGDTSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed